Advent International, the private equity firm based in Boston, Massachusetts, has agreed to invest over $300 million dollars for a 24.9% stake in Yatharth Hospitals, a hospital chain headquartered in the Delhi National Capital Region. The deal was first detailed by The Economic Times, which called it one of the largest primary-capital investments by a private equity firm in India’s hospital sector.
Founded in 2008, Yatharth Hospitals runs nine multi-specialty hospitals with 2,800 beds. Its hospitals are located across the National Capital Region, (including Noida, Greater Noida, Noida Extension, Greater Faridabad, New Delhi, Faridabad and Gurugram), plus Jhansi-Orchha and Agra. The stake sale is a minority investment, subject to customary closing conditions; the founding Tyagi family will remain the company’s largest shareholder afterward. Yatharth’s shares rose 9% in response.
Pankaj Patwari, Managing Director at Advent, said the investment “underscores Advent’s deep and longstanding commitment to India’s healthcare sector, which we believe is entering a decade of structural growth as access expands, quality improves, and consolidation advances.” He added that Advent is “pleased to partner with the Yatharth family, bringing our global healthcare expertise and experience investing in founder-led businesses.”
Advent has more than $109 billion in assets under management as of June 30, 2026, and has made 460 investments across forty-five countries, with more than thirty-five years of healthcare investing experience spanning fifty-five healthcare investments in seventeen countries. In India, its healthcare portfolio includes Apollo 24/7, the wellness and retail chain, along with several other India-based healthcare and pharmaceutical businesses, Yatharth is only Advent’s second direct hospital investment in India; the first was Care Hospitals, a hospital operator based in Hyderabad, in southern India, in 2012.
Yatharth is the latest India hospital operator to draw private equity money. Last month, the investment firm KKR agreed to acquire the India business of Medicover, a healthcare provider based in Sweden, for $1.4 billion. BPEA EQT acquired a majority stake in the fertility-services provider Indira IVF the same year.
For American investors, the deal is another sign that India’s private hospital networks, built to meet rising demand for care and expanding health insurance coverage, have become an active target for global private equity, alongside longer-running interest in India’s technology and manufacturing sectors.
